Team:Bielefeld-CeBiTec/Notebook/Journal/Isobutanol/Aug

From 2014.igem.org

(Difference between revisions)
Line 121: Line 121:
             <div class="content" style="margin-right:10%; margin-left:10%">
             <div class="content" style="margin-right:10%; margin-left:10%">
               <ul>
               <ul>
-
        <li><b><i>alsS</i>, <i>ilvC</i>, <i>ilvD</i>, <i>kivD</i> and backbone pSB1C3</b></li>
+
        <li><b><i>alsS</i>, <i>ilvC</i>, <i>ilvD</i>, <i>kivD</i> and backbone pSB1K3</b></li>
        <ul>
        <ul>
    <li>This week we tried to begin from zero again with optimized conditions and new competent cells. <br>Therefor we prepared new plasmids from <i>alsS</i>, <i>ilvC</i>, <i>ilvD</i>, <i>kivD</i> and the backbone pSB1K3-RFP</li>
    <li>This week we tried to begin from zero again with optimized conditions and new competent cells. <br>Therefor we prepared new plasmids from <i>alsS</i>, <i>ilvC</i>, <i>ilvD</i>, <i>kivD</i> and the backbone pSB1K3-RFP</li>
                     <ul>
                     <ul>
-
                       <li><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols#PCR" target="_blank">PCR amplification</a>)</li>
+
                       <li><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols#PCR" target="_blank">PCR amplification</a></li>
              <ul>
              <ul>
                           <li>Primer were used as described before</li>
                           <li>Primer were used as described before</li>
Line 132: Line 132:
          <li>Bands as expected for <br><i>alsS</i>: about 1.8 kb, <br><i>ilvC</i>: about  1.55 kb, <br><i>ilvD</i>: about 1.95 kb, <br><i>kivD</i>: about 1.7 kb, <br>but not for pSB1K3-RFP</li>
          <li>Bands as expected for <br><i>alsS</i>: about 1.8 kb, <br><i>ilvC</i>: about  1.55 kb, <br><i>ilvD</i>: about 1.95 kb, <br><i>kivD</i>: about 1.7 kb, <br>but not for pSB1K3-RFP</li>
              </ul>
              </ul>
-
                       <li><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols#PCR" target="_blank">PCR amplification</a>)</li> with Q5 for pSB1K3-RFP
+
                       <li><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols#PCR" target="_blank">PCR amplification</a></li> with Q5 for pSB1K3-RFP
                       <ul>
                       <ul>
                           <li>Primer were used as described before</li>
                           <li>Primer were used as described before</li>
Line 138: Line 138:
          <li>Bands as expected (about 2.2 kb)</li>
          <li>Bands as expected (about 2.2 kb)</li>
              </ul>
              </ul>
 +
                     
 +
              <li>PCR products were <a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols#DNAPurificationbyCentrifugation" target="_blank">purified</a></li>
 +
 +
                      <li><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols#Gibson" target="_blank">Gibson Assembly</a> with <i>kivD</i>, <i>alsS</i>, <i>ilvC</i> and  <i>ilvD</i> on pSB1K3</li>
                       <li><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols#RestrictionDigestion" target="_blank">Restriction digestion</a> with <a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/KitsAndEnzymes#RestrictionEnzymes" target="_blank"><i>DpnI</i></a></li>
                       <li><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols#RestrictionDigestion" target="_blank">Restriction digestion</a> with <a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/KitsAndEnzymes#RestrictionEnzymes" target="_blank"><i>DpnI</i></a></li>
              <ul>
              <ul>
                           <li>Aberation from protocol: Incubation for about 10 hours.</li>
                           <li>Aberation from protocol: Incubation for about 10 hours.</li>
-
          <li>Bands (not) as expected (... bp)</li>
+
              </ul><li><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols#Transformationviaelectroporation" target="_blank">Transformation</a> with electrocompotetent cells</li>
-
              </ul>
+
-
                      <li><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols#Gibson" target="_blank">Gibson Assembly</a> with <i>kivD</i>, <i>alsS</i>, <i>ilvC</i> and  <i>ilvD</i> on pSB1C3</li>
+
-
                      <li><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols#Transformationviaelectroporation" target="_blank">Transformation</a> with electrocompotetent cells</li>
+
                       <li><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols#ColonyPCR" target="_blank">Colony PCR</a> (<a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Primer#fw_ilvC_ilvD" target="_blank">fw_ilvC_ilvD</a>, <a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Primer#rv_pSB1C3_kivD" target="_blank">rv_pSB1C3_kivD</a>)</li>
                       <li><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols#ColonyPCR" target="_blank">Colony PCR</a> (<a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Primer#fw_ilvC_ilvD" target="_blank">fw_ilvC_ilvD</a>, <a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Primer#rv_pSB1C3_kivD" target="_blank">rv_pSB1C3_kivD</a>)</li>
              <ul>
              <ul>

Revision as of 15:58, 25 September 2014


August

  • psB1C3-alsS-ilvC-ilvD
  • alsS, ilvC, ilvD, kivD and backbone pSB1K3
    • This week we tried to begin from zero again with optimized conditions and new competent cells.
      Therefor we prepared new plasmids from alsS, ilvC, ilvD, kivD and the backbone pSB1K3-RFP